These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27432231)

  • 1. Involvement of hippocampal excitability in amyloid β-induced behavioral and psychological symptoms of dementia.
    Tamano H; Ide K; Adlard PA; Bush AI; Takeda A
    J Toxicol Sci; 2016; 41(4):449-57. PubMed ID: 27432231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation Housing Exacerbates Alzheimer's Disease-Like Pathophysiology in Aged APP/PS1 Mice.
    Huang H; Wang L; Cao M; Marshall C; Gao J; Xiao N; Hu G; Xiao M
    Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu116. PubMed ID: 25568286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior.
    Sharma S; Verma S; Kapoor M; Saini A; Nehru B
    Neurol Res; 2016 Sep; 38(9):838-50. PubMed ID: 27431920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced cognitive activity--over and above social or physical activity--is required to protect Alzheimer's mice against cognitive impairment, reduce Abeta deposition, and increase synaptic immunoreactivity.
    Cracchiolo JR; Mori T; Nazian SJ; Tan J; Potter H; Arendash GW
    Neurobiol Learn Mem; 2007 Oct; 88(3):277-94. PubMed ID: 17714960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral and psychological symptoms of dementia (BPSD) and impaired cognition reflect unsuccessful neuronal compensation in the pre-plaque stage and serve as early markers for Alzheimer's disease in the APP23 mouse model.
    Pfeffer A; Munder T; Schreyer S; Klein C; Rasińska J; Winter Y; Steiner B
    Behav Brain Res; 2018 Jul; 347():300-313. PubMed ID: 29572105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
    Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
    Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early cognitive stimulation compensates for memory and pathological changes in Tg2576 mice.
    Gerenu G; Dobarro M; Ramirez MJ; Gil-Bea FJ
    Biochim Biophys Acta; 2013 Jun; 1832(6):837-47. PubMed ID: 23474306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atorvastatin Prevents Cognitive Deficits Induced by Intracerebroventricular Amyloid-β1-40 Administration in Mice: Involvement of Glutamatergic and Antioxidant Systems.
    Martins WC; dos Santos VV; dos Santos AA; Vandresen-Filho S; Dal-Cim TA; de Oliveira KA; Mendes-de-Aguiar CB; Farina M; Prediger RD; Viola GG; Tasca CI
    Neurotox Res; 2015 Jul; 28(1):32-42. PubMed ID: 25827781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.
    Rammes G; Gravius A; Ruitenberg M; Wegener N; Chambon C; Sroka-Saidi K; Jeggo R; Staniaszek L; Spanswick D; O'Hare E; Palmer P; Kim EM; Bywalez W; Egger V; Parsons CG
    Neuropharmacology; 2015 May; 92():170-82. PubMed ID: 25637092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure to As-, Cd-, and Pb-mixture induces Aβ, amyloidogenic APP processing and cognitive impairments via oxidative stress-dependent neuroinflammation in young rats.
    Ashok A; Rai NK; Tripathi S; Bandyopadhyay S
    Toxicol Sci; 2015 Jan; 143(1):64-80. PubMed ID: 25288670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Amyloid β protein suppresses hippocampal theta rhythm and induces behavioral disinhibition and spatial memory deficit in rats].
    Yue XH; Liu XJ; Wu MN; Chen JY; Qi JS
    Sheng Li Xue Bao; 2014 Apr; 66(2):97-106. PubMed ID: 24777399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease.
    Srivareerat M; Tran TT; Alzoubi KH; Alkadhi KA
    Biol Psychiatry; 2009 Jun; 65(11):918-26. PubMed ID: 18849021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligonol improves memory and cognition under an amyloid β(25-35)-induced Alzheimer's mouse model.
    Choi YY; Maeda T; Fujii H; Yokozawa T; Kim HY; Cho EJ; Shibamoto T
    Nutr Res; 2014 Jul; 34(7):595-603. PubMed ID: 25150118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indoleamine-2,3-dioxygenase mediates neurobehavioral alterations induced by an intracerebroventricular injection of amyloid-β1-42 peptide in mice.
    Souza LC; Jesse CR; Antunes MS; Ruff JR; de Oliveira Espinosa D; Gomes NS; Donato F; Giacomeli R; Boeira SP
    Brain Behav Immun; 2016 Aug; 56():363-77. PubMed ID: 26965653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice.
    Santos DB; Peres KC; Ribeiro RP; Colle D; dos Santos AA; Moreira EL; Souza DO; Figueiredo CP; Farina M
    Exp Neurol; 2012 Feb; 233(2):767-75. PubMed ID: 22173317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of dietary EGCG and voluntary exercise on behavior in an Alzheimer's disease mouse model.
    Walker JM; Klakotskaia D; Ajit D; Weisman GA; Wood WG; Sun GY; Serfozo P; Simonyi A; Schachtman TR
    J Alzheimers Dis; 2015; 44(2):561-72. PubMed ID: 25318545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brilliant Blue G improves cognition in an animal model of Alzheimer's disease and inhibits amyloid-β-induced loss of filopodia and dendrite spines in hippocampal neurons.
    Chen X; Hu J; Jiang L; Xu S; Zheng B; Wang C; Zhang J; Wei X; Chang L; Wang Q
    Neuroscience; 2014 Oct; 279():94-101. PubMed ID: 25193238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer's beta-amyloid deposits.
    Cancino GI; Toledo EM; Leal NR; Hernandez DE; Yévenes LF; Inestrosa NC; Alvarez AR
    Brain; 2008 Sep; 131(Pt 9):2425-42. PubMed ID: 18559370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.